BIOLOGICAL E. LIMITED

Company Description

Established in 1953, Biological E Limited (BE) is a leading, world class Pharmaceutical and Biologics company with an impressive range of healthcare products. BE is the first private sector biological products company and a pioneer in the vaccine industry in India. BIOLOGICAL E. LIMITED take price in our historical and on going partnership with the Government of India in the National Immunization Program of the country. In addition, BE has built expertise in the areas of novel delivery sistems, strategic bulk activities and formulations. The BE business model has three core dimensions comprising of Biologics, Pharmaceuticals and Bulk Actives. BIOLOGICS BE produces and markets a range of paediatric and adult vaccines and has a significant market shre in the Indian vaccine market. In just a span of a decare, the company has delivered over 1.5 billion doses of vaccine towards the immunization needs in India. BE brings an enormous breadth of biologics ranging from bacterial vaccines - toxoids to polysaccharide conjugates and cell culture viral vaccines to recombinant proteins. Our current research focus comprises of developing low molecular weight heparins (LMWH), conjugate vaccines and a portfolio of flavivirus vaccines for unmet needs. PHARMACEUTICALS BE has a broad range of pharmaceutical formulations - oral dosages as well as injectables. This range of branded formulations encompass therapeutic segements of Non-Narcotic Cough Preparations, Digestive Enzymes and Vitamins, Anti-coagulants and Liver extracts, Anti-Infective and Antibiotics Haematenics. ACTIVE PHARMACEUTICAL INGREDIENTS (API) Strategically, the API division of BE supports the captive consumption needs of the company. Specializing in alkaloids such as Noscapine and its derivates and biologics such as Heparin, LMWN and PSGAG (Chondroitin Sulphate), BE has committed sgnificant investments to ensure a sustainable quality supply for the global markets.